A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries

In a context of therapeutic revolution in older adults with AML, it is becoming increasingly important to select patients for the various treatment options by taking account of short-term efficacy and toxicity as well as long-term survival. Here, the data from three European registries for 1,199 AML...

Descripción completa

Detalles Bibliográficos
Autores principales: Bérard, Emilie, Röllig, Christoph, Bertoli, Sarah, Pigneux, Arnaud, Tavitian, Suzanne, Kramer, Michael, Serve, Hubert, Bornhäuser, Martin, Platzbecker, Uwe, Müller-Tidow, Carsten, Baldus, Claudia D., Martínez-Cuadrón, David, Serrano, Josefina, Martínez-Sánchez, Pilar, Arbolí, Eduardo Rodríguez, Gil, Cristina, Bergua, Juan, Bernal, Teresa, de la Fuente Burguera, Adolfo, Delabesse, Eric, Bidet, Audrey, Dumas, Pierre-Yves, Montesinos, Pau, Récher, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276717/
https://www.ncbi.nlm.nih.gov/pubmed/35821023
http://dx.doi.org/10.1038/s41408-022-00700-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276717/
https://www.ncbi.nlm.nih.gov/pubmed/35821023
http://dx.doi.org/10.1038/s41408-022-00700-x

Ejemplares similares